2024-03-20 2025-03-31 false No description of principal activity Capium Accounts Production 1.1 15580032 2024-03-20 2025-03-31 15580032 bus:AbridgedAccounts 2024-03-20 2025-03-31 15580032 bus:FRS102 2024-03-20 2025-03-31 15580032 bus:AuditExemptWithAccountantsReport 2024-03-20 2025-03-31 15580032 bus:SmallCompaniesRegimeForAccounts 2024-03-20 2025-03-31 15580032 bus:PrivateLimitedCompanyLtd 2024-03-20 2025-03-31 15580032 2024-03-20 2025-03-31 15580032 2025-03-31 15580032 bus:RegisteredOffice 2024-03-20 2025-03-31 15580032 core:WithinOneYear 2025-03-31 15580032 core:AfterOneYear 2025-03-31 15580032 1 2024-03-20 2025-03-31 15580032 bus:Director1 2024-03-20 2025-03-31 15580032 bus:Director1 2025-03-31 15580032 2023-03-20 15580032 bus:LeadAgentIfApplicable 2024-03-20 2025-03-31 15580032 2024-03-19 15580032 bus:OrdinaryShareClass1 2024-03-20 2025-03-31 15580032 bus:OrdinaryShareClass1 2025-03-31 15580032 core:CostValuation core:Non-currentFinancialInstruments 2025-03-31 15580032 core:CostValuation core:Non-currentFinancialInstruments 2024-03-19 15580032 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-03-31 15580032 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-03-31 15580032 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-03-31 15580032 core:Non-currentFinancialInstruments 2025-03-31 15580032 core:Non-currentFinancialInstruments 2024-03-19 15580032 core:ShareCapital 2025-03-31 15580032 core:RetainedEarningsAccumulatedLosses 2025-03-31 15580032 dpl:Item1 2024-03-20 15580032 dpl:Item1 2025-03-31 iso4217:GBP xbrli:shares xbrli:pure
Logo On Report
Registered Number: 15580032


 

 

 

KPPERFUSION LIMITED



Abridged Accounts
 


Period of accounts

Start date: 20 March 2024

End date: 31 March 2025
Chartered Accountants' report to the board of directors on the preparation of the unaudited statutory accounts of KPPerfusion Limited for the year ended 31 March 2025.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of KPPerfusion Limited for the year ended 31 March 2025 which comprise of the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the company’s accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales, we are subject to its ethical and other professional requirements which are detailed at www.icaew.com/en/members/regulations-standards-and-guidance.
This report is made solely to the Board of Directors of KPPerfusion Limited , as a body, in accordance with the terms of our engagement letter dated 09 October 2025. Our work has been undertaken solely to prepare for your approval the accounts of KPPerfusion Limited and state those matters that we have agreed to state to the Board of Directors of KPPerfusion Limited , as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than KPPerfusion Limited and its Board of Directors as a body for our work or for this report.
It is your duty to ensure that KPPerfusion Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of KPPerfusion Limited . You consider that KPPerfusion Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the accounts of KPPerfusion Limited . For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts

31 March 2025.



....................................................
Kendall Accountancy Services Limited
2 Exeter Street
Cottingham
Hull
East Yorkshire
HU16 4LU
09 October 2025
1
 
 
Notes
 
2025
£
Current assets    
Cash at bank and in hand 500 
Creditors: amount falling due within one year (474)
Net current assets 26 
 
Total assets less current liabilities 26 
Net assets 26 
 

Capital and reserves
   
Called up share capital 3 100 
Profit and loss account (74)
Shareholders' funds 26 
 


For the period ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the director on 09 October 2025 and were signed by:


-------------------------------
Karolina Peszko
Director
2
General Information
KPPerfusion Limited is a private company, limited by shares, registered in , registration number 15580032, registration address Mayfair Apartments, Apartment 2 380 Beverley Road, Hull, East Yorkshire, HU5 1LN.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Taxation
Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted
2.

Average number of employees

Average number of employees during the period was 1.
3.

Share Capital

Allotted, called up and fully paid
2025
£
100 Class A shares of £1.00 each 100 
100 

3